Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06425848 · ClinicalTrials.gov registry record
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
A clinical trial of Heart Failure, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 12
- Study locations
NCT06425848: Recruiting study of Heart Failure, sponsored by University of Kansas Medical Center.
NCT06425848 is a study of Heart Failure that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 2,000 participants, roughly in line with the 2,044-participant average among 397 other Heart Failure trials with a reported enrollment target. The trial reports 12 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06425848, a study of Heart Failure, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 12
- Study locations
Study Summary
The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmonary artery pressure sensor at participating centers to advance scientific knowledge about ambulatory hemodynamics monitoring and HF (Heart Failure) therapies. The data collected will be used for retrospective studies, quality improvement, identifying research cohorts, and member-initiated research.
Primary Outcome
Hemodynamic data such as mean PA pressure in mmHg, PA systolic pressure in mmHg, PA diastolic pressures in mmHg, will be collected at the time of implant of PA pressure sensor and at 3 months, 6 months, 12 months, 24 months and 36 months post implant.
Conditions Studied
Interventions
- DEVICE Observational
Study Locations (12)
Minnesota
- Fairview Health - Maplewood
- Minneapolis Heart Institute Foundation/ Allina Health - Minneapolis
Texas
- Austin Heart - Austin
- Houston Methodist DeBakey Heart and Vascular Center - Houston
California
- Scripps Health - La Jolla
Indiana
- Indiana University - Bloomington
Kansas
- University of Kansas Medical Center - Kansas City
Missouri
- Saint Luke's Health System - Kansas City
North Carolina
- University of North Carolina/ Rex Hospital, Inc. - Raleigh
Oregon
- Providence Heart Institute - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2022-10-21 |
| Est. Completion | 2030-12-31 |
What NCT06425848 shows while recruiting
NCT06425848 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 2,044-participant average among 397 other Heart Failure trials with a reported enrollment target.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT06425848 lists 12 locations in 10 states (Minnesota, Texas, California).
Frequently Asked Questions
What is clinical trial NCT06425848 about?
NCT06425848 is a clinical study titled "HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry". The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmonary artery pressure sensor at participating centers to advance scientific knowledge about ambulator...
What is the current status of trial NCT06425848?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2022-10-21. Estimated completion is 2030-12-31.
What conditions does trial NCT06425848 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT06425848?
The interventions under investigation include: Observational (DEVICE).
Who is sponsoring clinical trial NCT06425848?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06425848 being conducted?
This trial has 12 study locations across California, Indiana, Kansas, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06425848's enrollment target sits among peer trials
2,000 44th of 397 higher than 354 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI